Comtech Telecommunications Corp. Receives $3.6 Million Contract Award for High-Power Amplifiers for Medical Application
June 19, 2018 at 9:00 AM EDT
MELVILLE, N.Y.--(BUSINESS WIRE)--
June 19, 2018--Comtech Telecommunications Corp. (Nasdaq:CMTL) announced
today that during its fourth quarter of fiscal 2018, its New York-based
subsidiary, Comtech PST Corp., which is part of Comtech's Government
Solutions segment, received a follow-on contract award for approximately
$3.6 million for solid-state, high-power RF amplifiers from a major
domestic medical instrumentation provider.
These amplifiers are used by one of the world's largest suppliers of
image-guided radiotherapy (IGRT) and image-guided intensity modulated
radiation therapy (IMRT) medical equipment providing state-of-the-art
solutions for the treatment of cancer. These advanced forms of treatment
deliver versatile complex doses of radiation at greater speed and
accuracy thereby minimizing damage to surrounding healthy tissue.
In commenting on this contract award, Fred Kornberg, President and Chief
Executive Officer of Comtech Telecommunications Corp., said, "This
significant award demonstrates Comtech's technical strength in
delivering solid-state, high-power RF amplifiers for medical systems. We
believe the medical market for our amplifiers remains strong and we look
forward to continuing to develop innovative products to address this
Comtech PST Corp. (www.comtechpst.com)
is a leading independent supplier of broadband, high-power, high
performance RF microwave amplifiers and control components for use in a
broad spectrum of applications including defense, radar, medical,
satellite communications systems and instrumentation.
Comtech Telecommunications Corp. designs, develops, produces and markets
innovative products, systems and services for advanced communications
solutions. The Company sells products to a diverse customer base in the
global commercial and government communications markets.
Certain information in this press release contains statements that are
forward-looking in nature and involve certain significant risks and
uncertainties. Actual results could differ materially from such
forward-looking information. The Company's Securities and Exchange
Commission filings identify many such risks and uncertainties. Any
forward-looking information in this press release is qualified in its
entirety by the risks and uncertainties described in such Securities and
Exchange Commission filings.